Kroger LA - Search Results

1

Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody.

DeNardo GL, DeNardo SJ, Lamborn KR, Goldstein DS, Levy NB, Lewis JP, O'Grady LF, Raventos A, Kroger LA, Macey DJ, McGahan JP, Mills SL, Shen S. DeNardo GL, et al. Among authors: kroger la. Cancer Biother Radiopharm. 1998 Aug;13(4):239-54. doi: 10.1089/cbr.1998.13.239. Cancer Biother Radiopharm. 1998. PMID: 10850360 Clinical Trial.

2

Characterization of human IgG antimouse antibody in patients with B-cell malignancies.

DeNardo GL, Mirick GR, Kroger LA, Bradt BM, Lamborn KR, DeNardo SJ. DeNardo GL, et al. Among authors: kroger la. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):4013S-21S. Clin Cancer Res. 2003. PMID: 14506202

3

Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.

Schillaci O, DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, O'Donnell RT, Lamborn KR. Schillaci O, et al. Among authors: kroger la. Cancer Biother Radiopharm. 2007 Aug;22(4):521-30. doi: 10.1089/cbr.2007.374A. Cancer Biother Radiopharm. 2007. PMID: 17803447

4

Efficient recombination of Lym-1 scFv gene using multiple doubly-restricted DNA fragments.

Shi XB, Gumerlock PH, Kroger L, DeNardo GL, DeNardo SJ. Shi XB, et al. Cancer Biother Radiopharm. 1999 Apr;14(2):139-43. doi: 10.1089/cbr.1999.14.139. Cancer Biother Radiopharm. 1999. PMID: 10850298

5

Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.

DeNardo GL, Lamborn KR, DeNardo SJ, Goldstein DS, Dolber-Smith EG, Kroger LA, Larkin EC, Shen S. DeNardo GL, et al. Among authors: kroger la. Cancer Res. 1995 Dec 1;55(23 Suppl):5893s-5898s. Cancer Res. 1995. PMID: 7493366

6

Analysis of antiglobulin (HAMA) response in a group of patients with B-lymphocytic malignancies treated with 131I-Lym-1.

De Nardo GL, Kroger LA, Mirick GR, Lamborn KR, De Nardo SJ. De Nardo GL, et al. Among authors: kroger la. Int J Biol Markers. 1995 Apr-Jun;10(2):67-74. doi: 10.1177/172460089501000201. Int J Biol Markers. 1995. PMID: 7561241 Clinical Trial.

7

The biologic window for chimeric L6 radioimmunotherapy.

DeNardo SJ, Mirick GR, Kroger LA, O'Grady LF, Erickson KL, Yuan A, Lamborn KR, Hellstrom I, Hellstrom KE, DeNardo GL. DeNardo SJ, et al. Among authors: kroger la. Cancer. 1994 Feb 1;73(3 Suppl):1023-32. doi: 10.1002/1097-0142(19940201)73:3+<1023::aid-cncr2820731341>3.0.co;2-u. Cancer. 1994. PMID: 8306244 Clinical Trial.

8

Overview of radiation myelotoxicity secondary to radioimmunotherapy using 131I-Lym-1 as a model.

DeNardo GL, DeNardo SJ, Macey DJ, Shen S, Kroger LA. DeNardo GL, et al. Among authors: kroger la. Cancer. 1994 Feb 1;73(3 Suppl):1038-48. doi: 10.1002/1097-0142(19940201)73:3+<1038::aid-cncr2820731343>3.0.co;2-8. Cancer. 1994. PMID: 8306246 Clinical Trial.

9

Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody.

Denardo SJ, O'Grady LF, Richman CM, Goldstein DS, O'Donnell RT, Denardo DA, Kroger LA, Lamborn KR, Hellström KE, Hellström I, Denardo GL. Denardo SJ, et al. Among authors: kroger la. Anticancer Res. 1997 May-Jun;17(3B):1745-51. Anticancer Res. 1997. PMID: 9179228 Clinical Trial.

10

Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma.

DeNardo SJ, Kroger LA, Lamborn KR, Miers LA, O'Donnell RT, Kukis DL, Richman CM, DeNardo GL. DeNardo SJ, et al. Among authors: kroger la. Cancer. 1997 Dec 15;80(12 Suppl):2583-90. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2583::aid-cncr34>3.3.co;2-8. Cancer. 1997. PMID: 9406713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page